Previously, Mr. McDonald served as Chief Operating Officer of LivaNova. Prior to that, he was Group Executive and Corporate Vice President at Danaher Corporation where he led a $1.5-billion group of dental consumables companies. Earlier in his tenure, he was Group President of Kerr where he and his team focused on building a strong research and development pipeline while improving operational performance utilizing the Danaher Business System. Additionally, Mr. McDonald previously led Zimmer’s spine division where he demonstrated his leadership skills, attracting a strong executive team that created a growth trajectory for the business unit. Earlier in his career, he worked with J&J’s Medical Device Franchises, including Ethicon, where he led marketing of the $2.5-billion medical device unit. 

Mr. McDonald earned an MBA at the Institute for Management Development (IMD) in Lausanne, Switzerland, along with a Master of Science in International Economics from the University of Wales, U.K. He also holds a Bachelor of Economics degree and Bachelor of Pharmacy degree, both from the University of Queensland, Australia. 

Mr. McDonald is a non-executive director of the regenerative medicine company Avita Medical (ASX:AVH). 

LinkedIn profile N/A

No bio available

LinkedIn profile N/A

Ryan Miller is Vice President, Strategy at LivaNova where he focuses on building the company’s capability in business processes and oversees its strategic planning process. Before joining LivaNova, Miller worked for Danaher where he held positions in global marketing, product management, business development and finance. He has expertise in working across complex matrixed organizations and delivering results through acquisitions, integration management and new product development. 

Miller holds an MBA from the Wharton School of Business and a B.S. in accounting from the University of Southern California. 

LinkedIn profile N/A

20+ years of experience leading teams of 50+ staff members from analysis of critical business issues to execution of strategies that achieved $100MM+ in bottom line benefit. A hands-on senior executive that led P&L, corporate wide improvements, cultural change and transformation initiatives delivering enterprise excellence. Led multiple programs and projects simultaneously with multi-million dollar budget responsibility. Broad background and a talent for developing highly motivated teams with the mutual goal of company growth and profitability.

Broad background developed through key leadership roles including Operations Management, Information Technology, Supply Chain, and Continuous Improvement Deployment. Certified Lean Six Sigma Black Belt, Design for Lean Six Sigma and Project Management Professional through PMI.

Specialties:
Operations Transformations
Lean Six Sigma
Operational Excellence
LSS Deployment in Operations, IT, services and functions
Manufacturing Operations
Plant Maintenance & Reliability
Baseline Assessment
Performance Management
Change Management
Large Scale Program & Project Management 

Click for LinkedIn profile

Experienced Vice President of Research and Development with a demonstrated history of growing individual and organizational capabilities through the application of solid engineering principals, continuous improvement, attention to detail and the application of customer focused strategic priorities. 
A strong R&D professional skilled in Class I, II and III Medical Devices, Embedded Systems, Firmware and Software Development, Electrical Engineering, Algorithms, Continuous Improvement, U.S. Food and Drug Administration (FDA), Model Based Development, Connected Healthcare Solutions and Business 
Development. 

Click for LinkedIn profile

Results oriented, customer focused senior manager with exceptional ability to align technology solutions with business strategies. Strong background in scientific research with over 14 years of experience in Information Technology managing enterprise portfolio of projects across different functional areas in bio-pharmaceutical industry including Discovery, Pre-Clinical and Clinical areas. Demonstrated ability to lead large high performing teams, streamline processes and increase productivity by utilizing business, scientific and technical knowledge. Proven track record of developing, implementing and enforcing policies and guidelines in FDA/EMA/MHRA/SOX regulated bio-pharmaceutical industry. Excellent people management and interpersonal skills with ability to interact well with all levels of executive management

Specialties: Enterprise Portfolio Management
Project & Program Management
People Management
Strategic Planning
Software Development Lifecycle (SDLC)
Laboratory Information Management Systems (LIMS)
Content Management
Imaging
Data Migrations
High Throughput Screening
Cheminformatics
System Validation
FDA/EMA/MHRA/SOX regulated
Change Management
ITIL
Database & Data Warehouse Technologies
Clinical Systems
Vendor Management
Offshore Team Management and Outsourcing
Contract Negotiations 

Click for LinkedIn profile

Thad Huston joined LivaNova after more than 25 years of healthcare experience at Johnson & Johnson (J&J) where he most recently served as Group Chief Financial Officer, Medical Devices. While at J&J, Huston was pivotal in accelerating the growth for many of its divisions through focused strategies, calculated investments in innovation and streamlined productivity. 

Huston held various other senior roles while at J&J, including: President of J&J’s Xian-Janssen Pharmaceuticals division in China; Vice President – Finance, Chief Financial Officer and Chief Operations Officer in J&J Pharmaceutical Research and Development; as well as Vice President – Finance and Chief Financial Officer at Ortho-McNeil Pharmaceuticals. Prior to this, he held senior financial roles at various J&J locations in the U.S., China, Belgium, Russia and Hungary.  

Huston is a Certified Management Accountant, and he holds a Bachelor of Science in finance with an emphasis in accounting from Pennsylvania State University. 

Click for LinkedIn profile

Well-established Vice President with over twenty years of professional experience most recently leading the accounting and tax departments of a global medical device company. Previously led the corporate accounting, finance and treasury operations for a multi-billion dollar international offshore drilling company. Extensive experience establishing new teams, reorganizing operations and developing leaders in a rapid growth environment. Accountable for strategic initiatives that maximize efficiency, reduce cost and mitigate risk. Stakeholder value and returns maximized through financial analysis, strategic partnerships and operations acuity. A motivational leader with a wide spectrum of abilities proven to deliver consistent results. 
 
Hands on experience with: 
 
• M&A Finance, Integration & Accounting • Budgeting, Forecasting & Analysis 
• Debt Offerings, Debt Buybacks & Credit Facilities • KPI/Business Intelligence Systems 
• Strategic Financial Planning & Analysis • Talent Development & Retention 
• SEC/FASB/U.K. GAAP • Enterprise Risk Management • ERP Conversions & Upgrades 
• Internal Controls, SOX & Management Systems • Treasury & Cash Management 

Click for LinkedIn profile

Dr. Olin joined Cyberonics in May 2009 as Vice President, Quality. In August 2009, he assumed additional responsibility for Clinical Affairs, and in April 2011, his responsibilities were expanded again to include Regulatory Affairs. With the 2015 merger between Cyberonics and Sorin, his responsibilities expanded to include corporate-wide responsibilities for the clinical, quality and regulatory affairs functions at LivaNova. 

Prior to May 2009, Olin was employed at Zeltiq Aesthetics, Inc., a privately held medical technology company in the San Francisco area, where he served as Sr. Director, Quality Assurance. Between 1999 and 2007, Olin was employed at the LifeScan and Cordis companies of Johnson & Johnson, holding several positions of increasing responsibility in quality assurance, statistics and clinical data management. Olin began his career with Procter & Gamble in 1993 after obtaining his Ph.D. in statistics from Iowa State University. 

He currently serves on the board of directors for the Medical Devices Innovation Consortium (MDIC) and as an industry representative on the Advisory Committee for The National Patient-Centered Clinical Research Network (PCORnet). 

Click for LinkedIn profile